Literature DB >> 7306020

Studies in vivo of the tissue uptake, cellular distribution and catabolic turnover of exogenous glucocerebrosidase in rat.

S Morrone, P G Pentchev, J Baynes, S Thorpe.   

Abstract

The kinetics of plasma clearance of highly purified human placental glucocerebrosidase in rats were biphasic with 75% of the infused dose showing a rapid clearance (t1/2 = 11 min) and the remaining 25% a considerably lower rate (t1/2 = 60 min). The majority of the enzyme (60%) was taken up by the liver. Although saturation kinetics for the clearance or uptake were not observed, the very high hepatic endocytic index (217 microliter/min) of glucocerebrosidase uptake indicated that liver uptake was mediated by an adsorptive endocytic process. Analysis of the cellular distribution of recovered glucocerebrosidase revealed predominantly parenchymal cell uptake with 38% of the exogenous enzyme in hepatocytes and only 2% in sinusoidal cells. High-mannose glycoproteins blocked hepatocyte and sinusoidal cell uptake of glucocerebrosidase equally. Kinetic experiments failed to demonstrate a transfer or shuttle of exogenous glucocerebrosidase from sinusoidal cells to hepatocytes. The possibility was raised that uptake of enzyme by the liver may be mediated by a common receptor that functions in both hepatocytes and sinusoidal cells. The catabolic turnover of exogenous glucocerebrosidase in rat liver was biphasic and the rate of decline was similar in hepatocytes and sinusoidal cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306020      PMCID: PMC1162808          DOI: 10.1042/bj1940733

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Studies of the reticuloendothelial system (RES). I. Measurement of the phagocytic capacity of the RES in man and dog.

Authors:  M IIO; H N WAGNER; U SCHEFFEL; B JABBOUR
Journal:  J Clin Invest       Date:  1963-03       Impact factor: 14.808

2.  Clearance of lysosomal hydrolases following intravenous infusion. Kinetic and competition experiments with beta-glucuronidase and N-acetyl-beta-D-glucosaminidase.

Authors:  P Stahl; J S Rodman; P Schlesinger
Journal:  Arch Biochem Biophys       Date:  1976-12       Impact factor: 4.013

Review 3.  The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins.

Authors:  G Ashwell; A G Morell
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1974

4.  Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher's disease.

Authors:  R O Brady; P G Pentchev; A E Gal; S R Hibbert; A S Dekaban
Journal:  N Engl J Med       Date:  1974-11-07       Impact factor: 91.245

5.  Isolation and characterization of glucocerebrosidase from human placental tissue.

Authors:  P G Pentchev; R O Brady; S R Hibbert; A E Gal; D Shapiro
Journal:  J Biol Chem       Date:  1973-08-10       Impact factor: 5.157

6.  The uptake and transport of exogenous proteins in mouse liver. Ultrastructural cytochemical studies with peroxidase tracers.

Authors:  R C Graham; S Limpert; R W Kellermeyer
Journal:  Lab Invest       Date:  1969-03       Impact factor: 5.662

7.  Investigations in enzyme replacement therapy in lipid storage diseases.

Authors:  R O Brady; P G Pentchev; A G Gal
Journal:  Fed Proc       Date:  1975-04

8.  Treatment of Gaucher's disease with liposome-entrapped glucocerebroside: beta-glucosidase.

Authors:  P E Belchetz; J C Crawley; I P Braidman; G Gregoriadis
Journal:  Lancet       Date:  1977-07-16       Impact factor: 79.321

9.  The sphingolipidoses.

Authors:  R O Brady
Journal:  N Engl J Med       Date:  1966-08-11       Impact factor: 91.245

10.  The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

Authors:  A E Bolton; W M Hunter
Journal:  Biochem J       Date:  1973-07       Impact factor: 3.857

View more
  3 in total

Review 1.  Alglucerase. A review of its therapeutic use in Gaucher's disease.

Authors:  R Whittington; K L Goa
Journal:  Drugs       Date:  1992-07       Impact factor: 9.546

2.  A biochemical and immunocytochemical study on the targeting of alglucerase in murine liver.

Authors:  R Willemsen; J J Tibbe; M A Kroos; B M Martin; A J Reuser; E I Ginns
Journal:  Histochem J       Date:  1995-08

Review 3.  Imiglucerase in the treatment of Gaucher disease: a history and perspective.

Authors:  Patrick B Deegan; Timothy M Cox
Journal:  Drug Des Devel Ther       Date:  2012-04-18       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.